You are here

Survey: Prescription Drug Costs Among Top Concerns for Medicare Beneficiaries

More than 20% report skipping doses or postponing refills (May 7)

More than one-third (37%) of Medicare Part D beneficiaries have daily concerns about their prescription drug costs, and 1 in 5 said they have had to make sacrifices, such as delaying filling a prescription or skipping doses, to help manage medication costs, according to a new survey conducted on behalf of Walgreens.

The survey examined the behaviors and understanding of seniors currently enrolled in Medicare Part D.

Despite most beneficiaries (77%) saying they had a clear understanding of their plan’s benefits, only half realized that co-pays for Part D prescriptions can vary by pharmacy; for instance, some plans feature preferred pharmacy networks that offer lower co-pays. Also, nearly 30% didn’t know that they can switch pharmacies at any time, believing falsely that it can only be done during Medicare’s annual election period (open enrollment). In addition, nearly 60% said that if they could change one thing about their Part D plan, it would be lower costs and co-pays.

The Medicare Part D beneficiaries surveyed took an average of eight prescriptions each week and spent an average of $58 per month on their co-pays, with nearly 2 in 10 (17%) paying more than $100. More than half (55%) of the seniors said that they would switch pharmacies if it meant savings on prescription drug costs.

The survey also found:

  • Most of the seniors were trying to lower prescription costs. Seven in 10 (72%) had switched to generic medications, and 4 in 10 (44%) were filling more 90-day prescriptions in an effort to save.
  • Only 15% of those surveyed were able to identify correctly the major components of national Part D prescription plans.
  • Only hospital/emergency room costs (40%) and caregiver/assisted living expenses (38%) were greater concerns for respondents than prescription drug costs (37%).

The survey was designed and conducted by KRC Research on behalf of Walgreens. The interviews were conducted by telephone between April 8 and April 15, 2013. A total of 1,000 U.S. Medicare Part D beneficiaries, aged 65 years and older, were interviewed.

Source: Walgreens; May 7, 2013.

More Headlines

First and Only Treatment Reduces Depressive Symptoms Within Days
Bone Marrow Cleared of Leukemia in Almost 60% of Patients
Combination of Two Drugs Could Reduce Tumor Growth
Pre-clinical Trials Showed Drug Inhibits Fibroblast Activity and Collagen Deposition
PARG Inhibitor Exploits Weakness, Kills Cells
Inexpensive, Wearable Therapy Increases Arm Mobility, Reduces Stiffness
Atezolizumab in Combination with Chemotherapy is the Only First-line Cancer Immunotherapy for ES-SCLC
National Statistics Report Factors In Race, Ethnicity for the First Time